Company profile

CardioSight company profile

CardioSight develops an intracardiac visualization and intervention platform designed for minimally invasive procedures. The device enables intracardiac guidance and delivery using direct, near-field optical visualization. CardioSight collaborates closely with contract developers for the design, development, and prototyping of the device, including in vitro testing at Semmelweis University and in vivo testing at Boston University. The company maintains a focus on core start-up management activities while relying on external partners for technical development and testing support.

Business identity

Phone number
+1-214-577-3507
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees

Headquarters

Headquarters
Budapest, Hungary
Country code
HU
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Pre Seed / 2024-04-30
Last equity funding
Pre Seed
Investors
1

Founders and investors

Investors

STRT Holding Nyrt

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.